Board and Management Team

Board

Martin-Blake

Dr Martin Blake

Chairman

MBBS, FRANZCR, FAANMS, MBA, FAICD

Dr Blake is a Radiologist and Nuclear Physician and brings a wealth of technical and industry experience to Resonance Health. He has been a partner of Perth Radiological Clinic since 1997 and is currently the Chairman of the company. Dr Blake additionally held the position of Head of Department of Nuclear Medicine at Royal Perth Hospital for a numbers of years. He has published more than a dozen peer review research papers and has been contributing author to the Royal Australian and New Zealand College of Radiologists (RANZCR) Imaging Guidelines. Dr Blake has additionally held positions as Secretary and Treasurer of the WA Branch of the RANZCR. Dr Blake has an MBA from Melbourne University, is a Graduate of the Australian Institute of Company Directors and holds directorships on a number of company boards.

Simon Panton

Mr Simon Panton

Non Executive Director

Mr Panton has been a major shareholder of Resonance Health since 2008 and joined the board in 2009, as he is strong believer in liver health technologies. Mr Panton started and ran his own successful small business for over 15 years and brings skills in business and marketing. He has experience in the property industry, financial markets, and the acquisition and disposal of investments. He currently manages assets and projects associated within family holdings and was a previous Non-Executive Director of 4DS Ltd.

 

Travis-Baroni

Dr Travis Baroni

Non Executive Director

Dr Travis Baroni has broad experience across industrial research, commercialisation of technology, asset valuations, and investment banking services. He has managed innovation development and technology strategy in a large company setting as well as being an active investor in early stage investments. He has worked in investment banking, providing advisory services to equity capital market transactions, corporate research, and valuations to clients.

 
 

Mitchell-Wells

Mr Mitchell Wells

Managing Director

Mr Mitchell Wells is an experienced senior executive and a qualified lawyer with commerical and legal experience in Australia, the United States of America and the United Kingdom. He has served as a director and worked as a senior executive of listed-public and private companies including ASX and Nasdaq listed companies. He currently serves as Chair of two not-for-profit organisations.

 

 

 

 

 
 

Mr Nick Allan

Chief Financial Officer and Company Secretary

Mr Nick Allan has over 25 years experience in commerce, corporate finance, accounting, information technology, corporate advisory and public practice.

After obtaining a Bachelor of Commerece from the University of Western Australia, Mr Allan qualified as a Chartered Accountant in the UK with Coopers & Lybrand, and later worked with JP Morgan in their European M&A Division.

After returning to Australia, Mr Allan worked at Deloitte and Ernst & Young in their corporate finance departments, and also with Patersons Securities.

Since 2007, Mr Allan has provided corporate advisory, general management and IT consulting services to a wide variety of companies. He has been Chief Financial Officer and Company Secretary of ASX-listed public companies.

 
 

Dr Wenjie PangDr Wenjie Pang

Technical & Research Manager

PhD

Wenjie hails from China, where he enjoyed a successful career researching magnetism in different forms. He came to the University of Western Australia as a visiting research fellow in the Department of Physics. Following an International Scholarship to study for his PhD and some time at the University of Colorado in the US, Wenjie became one of the first employees of Resonance Health in 2005.

Wenjie’ s roles in the company have been pivotal and varied. He has been heavily involved in R&D across FerriScan, HepaFat-Scan and liver fibrosis measurement and his work has also resulted in a significant shortening of the MRI scan time required for FerriScan. Most recently Wenjie has worked closely with the marketing team to explore the market in China and provide clinical education.

Since moving to Western Australia, Wenjie and his wife greeted the arrival of their second child, and he enjoys playing bridge and various sports in his spare time.

 
 

Dr Sherif Boulos

Clinical Research Manager

PhD

Sherif is tasked with identifying and co-ordinating clinical studies in which Resonance Health’s products can add value.  With a focus on HepaFat-Scan and our developing liver fibrosis technology, his work has already led to a number of new and important studies in the NAFLD/NASH and diabetes fields.

Prior to joining Resonance Health, he established a research laboratory investigating brain diseases while teaching undergraduates and supervising post-graduate students. Well before this time, he worked as a sales engineer, product specialist, and technical sales executive with a number of medical and laboratory supply companies. Combined, his working life has spanned both the academic and commercial worlds.

Married with two teenaged children, he enjoys Perth’s abundant coastal lifestyle while occasionally finding time to play guitar.

 
 

Assoc. Prof. Michael House

Scientific Research Officer

PhD

Research Associate Professor Michael House is a biophysicist in the School of Physics at The University of Western Australia and a Scientific Research Officer at Resonance Health. He has extensive experience in quantitative magnetic resonance imaging (MRI) techniques to non-invasively assess human diseases including Alzheimer’s disease, liver fibrosis and steatosis, and iron overload in the brain, heart, kidneys, liver and bone marrow and has published over 50 peer-reviewed articles and abstracts. His expertise in quantitative MRI techniques provides an important contribution to the R&D team in Resonance Health's commitment to enhance existing products and broaden its portfolio. He is also one of the inventors listed on the international patent application for the non-invasive measurement of liver fat (HepaFat-Scan).